The World Health Organisation (WHO) is starting vaccination against yellow fever in Borno State in northeast Nigeria. 

It says it's part of efforts toward eliminating the disease in Nigeria. 

Field Communication Officer of the organisation, Chima Omiekwe, told reporters in Maiduguri on Friday that the campaign would commence on Tuesday and end on February 14, 2019. 

The exercise would be conducted in 288 political wards across the 25 local government areas in the state. 

He explained that the campaign is aimed at reducing yellow fever transmission in line with the strategy to eliminate Yellow Fever by 2026. 

The target groups were between nine months to 45 years, especially among Internally Displaced Persons (IDPs). 

Omiekwe said at least 3,000 health workers, opinion leaders, community leaders and primary teachers would be involved in the process.


According to him, the surveillance component will enable to rapidly contributors detect, investigate and respond to any suspected or confirmed case of yellow fever. 

“The first phase of the campaign will be conducted in some designated camps and host communities in Jere, Konduga, MMC and Mafa councils. 

“We are focusing on the IDPs because of the risk assessment in camps. As you know, a lot of these IDPs are living in bad sanitary conditions. 

“They are living in an environment that is prone to diseases,” he said. 

He stated that about one million doses of vaccine would be administered during the period. 

Yellow fever is an acute viral haemorrhagic disease transmitted by infected mosquitoes.

The "yellow" in the name refers to the jaundice that affects some patients.

Also Read: Latest Figure For Lassa Fever Cases, Deaths Highlight Lapses

Some known symptoms of yellow fever are fever, headache, jaundice, muscle pain, nausea, vomiting and fatigue.

A small proportion of patients who contract the virus develop severe symptoms and approximately half of those die within 7 to 10 days.

The virus is endemic in tropical areas of Africa and Central and South America.